Summary
This Form 8-K filing by WellPoint, Inc. (now Elevance Health) on November 2, 2006, primarily details changes to its executive compensation and employment agreements. The Compensation Committee approved a new Executive Agreement Plan, replacing the previous Severance Plan, with key modifications to the definitions of 'cause' and 'good reason,' notably extending some 'good reason' provisions to apply even without a change in control. This aims to provide enhanced protection and clarity for key executives. Furthermore, the filing discloses a new employment agreement for John S. Watts, Jr., President and CEO for Commercial and Consumer Business, and significant equity awards granted to him. These include a stock option grant for 40,000 shares and a restricted stock award for 20,000 shares, both vesting over two years. These actions underscore the company's focus on retaining and incentivizing senior leadership through robust compensation structures.
Key Highlights
- 1WellPoint, Inc. (now Elevance Health) adopted a new Executive Agreement Plan, superseding the prior Executive Severance Plan.
- 2Key changes to the Executive Plan include modifications to the definitions of 'cause' and 'good reason' for executive termination.
- 3The definition of 'good reason' now includes provisions for salary reduction (over 10% not generally applicable), relocation over 50 miles, or breach of agreement, applicable even without a change in control.
- 4John S. Watts, Jr., President and CEO for Commercial and Consumer Business, entered into a new employment agreement.
- 5Mr. Watts received a stock option grant for 40,000 shares with an exercise price of $75.13 (closing market value on Nov 1, 2006).
- 6Mr. Watts also received a restricted stock award for 20,000 shares.
- 7Both equity grants to Mr. Watts are subject to a two-year vesting schedule, with equal installments on November 1, 2008, and November 1, 2009.